Sterile lyophilized NAD+ powder vials for intravenous and subcutaneous wellness/anti-ageing therapy
Dietary supplement; injectable NAD+ (nicotinamide adenine dinucleotide) lyophilized powder for IV and subcutaneous use in aesthetic and wellness clinics
Certifications
The supplier states that the NAD+ lyophilized powder vials are manufactured in accordance with European regulatory standards and that production adheres to the highest EMA and FDA regulations, with sterile, aseptic vial filling under GMP (Good Manufacturing Practice) standards.
Sterilisation is described as using ultrafiltration, and quality assurance includes certificate Of Analysis testing for sterility, micro Organisms, toxicity, heavy metals and compound purity, with a minimum purity specification of greater than 98% NAD+.
The supplier states that the NAD+ lyophilized powder vials are manufactured in accordance with European regulatory standards and that production adheres to the highest EMA and FDA regulations, with sterile, aseptic vial filling under GMP (Good Manufacturing Practice) standards.
Sterilisation is described as using ultrafiltration, and quality assurance includes certificate Of Analysis testing for sterility, micro Organisms, toxicity, heavy metals and compound purity, with a minimum purity specification of greater than 98% NAD+.
Regulatory status on the supplier’s product page: NAD+ is categorised as a dietary supplement under CAS 53 84 9 and HS code 2934999090 in line with ECICS classification of the European Union, rather than as a licensed medicinal product requiring a marketing authorisation.
Description
NAD+ Wholesale from Vitamin Injections London consists of sterile lyophilized NAD+ (nicotinamide adenine dinucleotide) powder vials intended for reconstitution and administration by trained professionals via intravenous infusion or subcutaneous injection. The product is supplied as 500 mg or 1000 mg NAD+ per vial in 5 ml or 10 ml vials and is promoted for clinic use in anti-ageing and wellness protocols, with marketing materials highlighting the role of NAD+ as a vitamin B3-derived coenzyme essential for cellular energy metabolism, DNA repair, cell growth and survival and noting that endogenous NAD+ levels decline with age. The supplier states that the vials contain >98% pure NAD+ manufactured under GMP conditions with aseptic vial filling and ultrafiltration, and that the product is categorised as a dietary supplement rather than a licensed medicinal product; it is intended to support well-being and is explicitly not presented as a substitute for professional medical advice or conventional medical treatment.
Bnefits
Provides sterile lyophilized NAD+ powder in 500 mg and 1000 mg strengths for reconstitution and administration by trained professionals (intravenous or subcutaneous use).
Supplies high-purity (>98%) NAD+ (nicotinamide adenine dinucleotide), a coenzyme involved in cellular energy metabolism, DNA repair, cell growth and cell survival.
Marketed to aesthetic and wellness clinics as a premium NAD+ product to support anti-ageing and general well-being in IV therapy protocols.
Manufactured using sterile and aseptic vial filling processes that the supplier states comply with EMA and FDA regulations and GMP standards.
Comprehensive certificate-of-analysis (COA) testing is claimed by the supplier, including checks for sterility, micro-organisms, toxicity, heavy metals and compound purity.
Shelf life of at least two years from the batch COA date when stored correctly, allowing for medium-term stock holding by clinics.
Storage guidance allows for cool, dark storage around 5 °C with freezing permitted, which is practical for clinic refrigerators.
Supplier emphasises that one vial can be split into several treatments, allowing clinics to divide contents across multiple IV or subcutaneous sessions.
Regulatory status on the supplier’s product page: NAD+ is categorised as a dietary supplement under CAS 53 84 9 and HS code 2934999090 in line with ECICS classification of the European Union, rather than as a licensed medicinal product requiring a marketing authorisation.
Independent reporting on NAD+ infusions in the UK notes that NAD+ intravenous products are unlicensed for medical use and have been scrutinised by regulators such as the MHRA when marketed with medicinal claims, underlining that NAD+ IV infusions are not approved medicines in the UK.
No MHRA product licence (PL) number, EMA European Public Assessment Report (EPAR), CE/UKCA medical device certification or official medicinal SmPC is publicly listed for this specific NAD+ lyophilized powder vial product.
Independent reporting on NAD+ infusions in the UK notes that NAD+ intravenous products are unlicensed for medical use and have been scrutinised by regulators such as the MHRA when marketed with medicinal claims, underlining that NAD+ IV infusions are not approved medicines in the UK.
No MHRA product licence (PL) number, EMA European Public Assessment Report (EPAR), CE/UKCA medical device certification or official medicinal SmPC is publicly listed for this specific NAD+ lyophilized powder vial product.
Dietary supplement; injectable NAD+ (nicotinamide adenine dinucleotide) lyophilized powder for IV and subcutaneous use in aesthetic and wellness clinics
Intended use as described by the supplier: sterile lyophilized NAD+ powder vials for intravenous and subcutaneous administration by trained professional practitioners in clinic settings.
Marketed to support cellular energy metabolism, DNA repair, cell growth and survival, with claims that boosting NAD+ levels may help address age-related declines in NAD+ associated with ageing symptoms and certain health conditions.
Promoted in the context of wellness and anti-ageing IV therapies rather than as a licensed treatment for specific medical diseases, with a disclaimer that the product is intended to support well-being and is not a substitute for professional medical advice.
Categorised by the supplier as a dietary supplement under CAS number 53-84-9 and HS code 2934999090 according to ECICS of the European Union.
Composition
Active substance: NAD+ (nicotinamide adenine dinucleotide), a vitamin B3-derived coenzyme with empirical formula C21H27N7O14P2 and molecular weight approximately 663.43 g/mol.
Supplier states minimum purity of greater than 98% NAD+ in the lyophilized powder.
Product is identified under CAS number 53-84-9 and HS code 2934999090 in supplier regulatory information, reflecting its classification as a dietary supplement/raw material rather than a licensed medicinal product.
No additional excipients, stabilisers or buffer components are publicly listed by the supplier for these vials; the detailed formulation beyond NAD+ content is not publicly disclosed.
Formulation
Sterile lyophilized (freeze-dried) NAD+ powder in single-use glass vials intended to be reconstituted with sterile water or 0.9% saline prior to use.
Available strengths: 500 mg NAD+ per vial and 1000 mg NAD+ per vial.
Vial sizes: 5 ml and 10 ml vials corresponding to the stated 500 mg and 1000 mg presentations.
Described by the supplier as a vitamin B3 derivative and coenzyme product for intravenous and subcutaneous administration in wellness and anti-ageing protocols.
Packaging
Supplied as individual amber glass vials containing sterile lyophilized NAD+ powder (visuals show a brown glass vial with a crimped closure and printed product label).
Vial sizes stated as 5 ml and 10 ml corresponding to NAD+ 500 mg and 1000 mg strengths.
Wholesale minimum order quantity specified as 10 vials per order.
External carton, secondary packaging details and exact labelling text beyond what is visible in the product images are not publicly listed.
Usage
The supplier states that the product is for trained/professional practitioners only and is intended for intravenous and subcutaneous use in clinics.
Reconstitution preparation: gather a lyophilized NAD+ vial, sterile water or 0.9% saline, syringe, needle, alcohol swabs and optionally a 500 ml 0.9% sodium chloride IV bag; maintain a sterile work area and wear gloves.
Vial preparation: inspect the vial for damage and disinfect the rubber stopper with an alcohol swab before reconstitution.
Reconstitution procedure (general): inject 5 ml of sterile water or saline into the vial and swirl gently to dissolve the lyophilized NAD+ powder, avoiding excessive agitation; ensure the resulting solution is clear and free of visible particles.
For IV infusion, the supplier advises transferring the reconstituted solution to a 500 ml 0.9% saline IV bag before administration.
For subcutaneous injection using a 1000 mg vial, instructions describe injecting 1 ml of sterile water or saline into the vial, gently swirling to dissolve and then drawing 100 mg for subcutaneous injection, with additional guidance for drawing 0.5 units on an insulin syringe if the same vial is used for IV dosing.
IV administration guidance includes starting the drip slowly and adjusting the flow rate according to client tolerance during the first 20 minutes, monitoring for dizziness, increased heart rate or abdominal discomfort and adjusting accordingly.
Typical infusion duration stated as approximately 3–4 hours for a 500 mg NAD+ IV drip.
The supplier advises consulting a doctor before proceeding with treatment if the client has heart conditions, is pregnant, has a pacemaker or has cancer.
The product information emphasises that it is intended to support well-being and is not a substitute for professional medical advice; treatment planning and dosing are left to the discretion of qualified practitioners rather than fixed in the publicly available description.
Contraindications
Formal medicinal contraindications (such as those found in an SmPC for a licensed medicine) are not publicly listed for this NAD+ lyophilized powder dietary supplement product.
Supplier advisory: clients with heart conditions, pregnancy, pacemakers or cancer are specifically advised to consult a doctor before proceeding with NAD+ IV or subcutaneous treatment.
Adverse Effects
Not publicly listed (no formal adverse reaction profile or frequency table comparable to a medicinal product SmPC is published for this NAD+ dietary supplement product).
Storage Conditions
Supplier storage guidance: store the lyophilized NAD+ vials in dark, cool conditions, with an optimal storage temperature of approximately 5 °C.
Freezing of the product is described as permissible by the supplier.
Shelf life is stated as at least two years from the batch certificate-of-analysis (COA) date when stored under recommended conditions.
No additional specific requirements for light protection, humidity control or in-use storage after reconstitution are publicly detailed beyond the general cool, dark storage advice.
Duration
Publicly available information specifies that a typical intravenous infusion time for a 500 mg NAD+ drip using this product is approximately 3\u20134 hours; no standardised overall course length (number of sessions or duration of therapy) is publicly listed by the supplier and is left to practitioner discretion.
